Michael Gelband’s Mesoblast MESO Stock Holding History

Michael Gelband’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,854	Closed	-$218K	–	2212
2020 Q3	$218K	Buy	+5,854	New	+$183K	﹤0.01%	1435

Other funds holding MESO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $443M AUM 46.78% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Michael Gelband's MESO Position: Q4 2020 in Review

Michael Gelband sold out of Mesoblast (MESO) in Q4 2020, closing a stake of 5,854 shares — an estimated $218K sold.

Michael Gelband first reported a position in MESO in Q3 2020 and held it in 1 quarter. The position peaked at $218K in Q3 2020. 53 funds tracked by Wall St. Rank hold MESO as of Q4 2020.

Michael Gelband reported no remaining Mesoblast position as of Q4 2020 after selling out during the quarter.
Michael Gelband sold 5,854 Mesoblast shares in Q4 2020, an estimated $218K.
Michael Gelband first reported a position in Mesoblast in Q3 2020 and held it in 1 quarter.
Michael Gelband's Mesoblast position peaked at $218K in Q3 2020.
53 funds tracked by Wall St. Rank held Mesoblast as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.